Meng Chao Hepatobiliary Hospital of Fujian Medical University
2 clinical trials · Sponsor
◉ Watch Meng Chao Hepatobiliary Hospital of Fujian Medical University
| Record | Firm | Date |
|---|---|---|
| A Trial of Cadonilimab Plus Regorafenib in Patients With Hepatocellular Carcinoma Who Failed Camrelizumab Combined With Apatinib (NCT06280105) | Meng Chao Hepatobiliary Hospital of Fujian Medical University | 2024-03-31 |
| A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma (NCT05409482) | Meng Chao Hepatobiliary Hospital of Fujian Medical University | 2022-08-20 |
Track Meng Chao Hepatobiliary Hospital of Fujian Medical University automatically
Every clearance here is in the API, with alerts when new ones post.